Unknown

Dataset Information

0

A new sensitizer DVDMS combined with multiple focused ultrasound treatments: an effective antitumor strategy.


ABSTRACT: Sonodynamic therapy (SDT) was developed as a promising noninvasive approach. The present study investigated the antitumor effect of a new sensitizer (sinoporphyrin sodium, referred to as DVDMS) combined with multiple ultrasound treatments on sarcoma 180 both in vitro and in vivo. The combined treatment significantly suppressed cell viability, potentiated apoptosis, and markedly inhibited angiogenesis in vivo. In vivo, the tumor weight inhibition ratio reached 89.82% fifteen days after three sonication treatments plus DVDMS. This effect was stronger than one ultrasound alone (32.56%) and than one round of sonication plus DVDMS (59.33%). DVDMS combined with multiple focused ultrasound treatments initiated tumor tissue destruction, induced cancer cell apoptosis, inhibited tumor angiogenesis, suppressed cancer cell proliferation, and decreased VEGF and PCNA expression levels. Moreover, the treatment did not show obvious signs of side effects or induce a drop in body weight. These results indicated that DVDMS combined with multiple focused ultrasounds may be a promising strategy against solid tumor.

SUBMITTER: Xiong W 

PROVIDER: S-EPMC4668354 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

A new sensitizer DVDMS combined with multiple focused ultrasound treatments: an effective antitumor strategy.

Xiong Wenli W   Wang Pan P   Hu Jianmin J   Jia Yali Y   Wu Lijie L   Chen Xiyang X   Liu Quanhong Q   Wang Xiaobing X  

Scientific reports 20151203


Sonodynamic therapy (SDT) was developed as a promising noninvasive approach. The present study investigated the antitumor effect of a new sensitizer (sinoporphyrin sodium, referred to as DVDMS) combined with multiple ultrasound treatments on sarcoma 180 both in vitro and in vivo. The combined treatment significantly suppressed cell viability, potentiated apoptosis, and markedly inhibited angiogenesis in vivo. In vivo, the tumor weight inhibition ratio reached 89.82% fifteen days after three soni  ...[more]

Similar Datasets

| S-EPMC10232610 | biostudies-literature
2025-09-03 | GSE267237 | GEO
| S-EPMC9315635 | biostudies-literature
| S-EPMC7380053 | biostudies-literature
2025-09-03 | GSE267445 | GEO
| S-EPMC6713759 | biostudies-literature
| S-EPMC9784431 | biostudies-literature
| S-EPMC8308978 | biostudies-literature
| S-EPMC6549349 | biostudies-literature
| S-EPMC11022700 | biostudies-literature